Upregulation of SPP1 Is a Marker for Poor Lung Cancer Prognosis and Contributes to Cancer Progression and Cisplatin Resistance

The chemoresistance of lung cancer is a significant contributor to its high mortality and morbidity rate. There is an urgent need to identify differentially expressed genes in lung cancer patients with a poor prognosis to develop effective means to overcome drug resistance in subsequent treatment. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Huaping, Chen, Jianyou, Han, Xiaolei, Feng, Yan, Wang, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116663/
https://www.ncbi.nlm.nih.gov/pubmed/33996808
http://dx.doi.org/10.3389/fcell.2021.646390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116663/
https://www.ncbi.nlm.nih.gov/pubmed/33996808
http://dx.doi.org/10.3389/fcell.2021.646390

Ejemplares similares